APA

Raskob G. E., Gallus A. S., Sanders P., Thompson J. R., Agnelli G., Buller H. R., Cohen A. T., Ramacciotti E. & Weitz J. I. (20161230). Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial. : Thrombosis and haemostasis.

Chicago

Raskob Gary E, Gallus Alex S, Sanders Paul, Thompson John R, Agnelli Giancarlo, Buller Harry R, Cohen Alexander T, Ramacciotti Eduardo and Weitz Jeffrey I. 20161230. Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial. : Thrombosis and haemostasis.

Harvard

Raskob G. E., Gallus A. S., Sanders P., Thompson J. R., Agnelli G., Buller H. R., Cohen A. T., Ramacciotti E. and Weitz J. I. (20161230). Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial. : Thrombosis and haemostasis.

MLA

Raskob Gary E, Gallus Alex S, Sanders Paul, Thompson John R, Agnelli Giancarlo, Buller Harry R, Cohen Alexander T, Ramacciotti Eduardo and Weitz Jeffrey I. Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial. : Thrombosis and haemostasis. 20161230.